Drug Database · Clinicians

Dimenhydrinate

Brands (1) NedzadinShow all

US brand (reference label): Motion Sickness Relief; not a Philippine-registered brand.

Antiemetic; Anti-emetic PH FDA category

Rx · Prescription drug3 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID c4077301-db6c-473d-beb3-232d7134a13a, version date September 30, 2026 (Motion Sickness Relief · Amerisource Bergen). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
US FDA label
Full indications and usage US FDA label

Uses for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions do not take more than directed to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness, see below: adults and children 12 years and over ■ take 1 to 2 tablets every 4-6 hours ■ do not take more than 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years ■ give 1/2 to 1 tablet every 6-8 hours ■ do not give more than 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years ■ give 1/2 tablet every 6-8 hours ■ do not give more than 1 1/2 tablets in 24 hours, or as directed by a doctor

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Tablet: 25 mg, 50 mg
  • Syrup: 12.5 mg/5 mL

Registered products in the Philippines

3 products registered with the Food and Drug Administration (FDA) Philippines list Dimenhydrinate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products3
Philippine FDA-registered products for Dimenhydrinate
Package insert
NedzadinDimenhydrinate
12.5 mg/5 mL SyrupAmber Glass Bottle x 60 mL
Rx
Drugmakers Laboratories, IncPhilippines
—
DRP-5551
Jan 27, 2030
NedzadinDimenhydrinate
25 mg TabletAlu/Clear PVC Blister pack x 20's (Box of 100's)
Rx
Drugmaker's Laboratories, Inc.Philippines
—
DRP-5724
Apr 29, 2029
NoneDimenhydrinate
50 mg TabletBlister Pack x 20's (Box of 100's)
Rx
Drugmakers Laboratories IncPhilippines
—
DRP-5827
May 16, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Do not use for children under 2 years of age unless directed by a doctor. Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

When using this product marked drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Motion Sickness Relief · Amerisource Bergen [US FDA-approved label, version 13, September 30, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4077301-db6c-473d-beb3-232d7134a13a
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .